Transcutaneous Nerve Stimulator (TENS)

DEVICE2 trials

Sponsors

Elira Therapeutics, Inc.

Conditions

ObesityOverweightWeight Loss

Unknown Phase

Safety and Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS)-Assisted Weight Loss

TerminatedNCT03299881

Elira Therapeutics, Inc.Obesity, Overweight

Start: 2017-09-05End: 2018-04-01Updated: 2021-11-10

ELIRA 2: Safety and Effectiveness of TENS Assisted Weight Loss and Appetite Suppression

CompletedNCT03936699

Elira Therapeutics, Inc.Weight Loss

Start: 2018-06-22End: 2019-05-30Updated: 2022-02-02